-
5m 43sPart 3 | Session 6 STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS
-
5m 41sPart 3 | Session 7 SPLENDOR: Metabolic Surgery and Risk of MACE in NASH
-
5m 11s
-
6m 9sPart 3 | Session 9 VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes
-
5m 50sPart 3 | Session 10 Micra CED: 2-Year Outcomes with Leadless Pacing
-
10m 53sPart 3 | Session 11 RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes
-
20m 32s
-
25m 18sPart 1 | Session 1 View from the Thoraxcenter – What's Hot at ESC 2021
-
36m 1sPart 1 | Session 2 View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up
-
19m 47sPart 2 | Session 1 ESC 2021 Discussion: The EMPEROR-Preserved Trial
-
15m 2sPart 2 | Session 2 ESC 2021 Discussion: The FIGARO-DKD Trial
-
20m 8sPart 2 | Session 3 ESC 2021 Discussion: The EMPEROR-Pooled Study
-
6m 33s
-
4m 39sPart 3 | Session 2 SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI
-
8m 40sPart 3 | Session 3 TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI
-
5m 21sPart 3 | Session 4 The LAAOS III Study: Surgical AFIB Ablation Evaluation
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science results and spotlight impactful data.
For a deeper dive into key clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series.
Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Faculty Biographies
George D Dangas
Director of Cardiovascular Innovation
Dr. Dangas is a Professor of Medicine (Cardiology) and Surgery (Vascular) at the Icahn School of Medicine at Mount Sinai, Director of Cardiovascular Innovation at the Cardiovascular Institute of the Mount Sinai Medical Center, New York City, and the Director of the Medical School Course Cardiology. He is a Founding Physician of the Cardiovascular Research Foundation in New York City.
George is trained in internal medicine at the Miriam Hospital/Brown University in Rhode Island, and in cardiovascular disease and interventional cardiology at the Mount Sinai Hospital in New York City.
He has authored over 500 publications, including an international referral textbook on Interventional Cardiology Principles & Practice. Additionally, he is a course director and invited/featured speaker in many of the highest ranked cardiovascular conferences worldwide.
George has received Fellowship distinction in seven national and international…